The Tesla CEO told X users he is currently taking Mounjaro because it “seems to have fewer side effects and be more effective” than Ozempic.

Elon Musk showed off a trimmer figure in a holiday social media post on Wednesday while revealing that he has been taking an ...

MassHealth is transitioning coverage for anti-obesity drugs, designating Zepbound as the preferred option starting in January 2025, with Wegovy and Saxenda being discontinued for most adult members.

Elon Musk reveals he’s taking drug for weight loss in bizarre ‘Ozempic Santa’ post - The world’s richest man has clashed with ...

The U.S. Food and Drug Administration has approved the first generic version of Victoza (liraglutide injection), ...

Lower interest rates boost biotech investments by increasing risk appetite, benefiting pre-commercial biotechs. Read more on how these companies may perform in 2025.

DOGE co-chair Elon Musk shocked his followers on Christmas Day by posting a tweet of his trimmed-down self in a Santa outfit.

Amidst a race with its competitors to produce the next smash-hit weight loss drug, Novo Nordisk 's ( NVO 0.15%) stock crashed ...

California’s Medicaid program spent the most of all states on GLP-1 coverage, exceeding $1.4 billion, or $118 per enrollee.

Savannah Mendoza used to spend most of her paychecks on food delivery apps and at fast food drive-thrus, trying to satisfy a ...

Musk's endorsement highlights the skyrocketing demand for GLP-1 inhibitors, drugs originally meant for diabetes but now the ...

Elon Musk took to X on Wednesday to revel in the Christmas spirit. He also reportedly credited Mounjaro for his weight loss.